CLINICAL_TRIALS ClinicalTrials.gov record update

IntenSify: an Open-label Phase I Trial of the CYP3A Inhibitor Cobicistat and the Cytostatics Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma to Evaluate the Combination's Pharmacokinetics, Safety and Efficacy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05494866
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:42.079323+00:00
Published At: 2025-03-25T00:00:00+00:00
Record Updated At: 2025-03-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["CYP3A Inhibitor", "Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma", "Pancreatic Cancer", "Pancreatic Adenocarcinoma", "Pancreatic Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-25"
protocolSection.identificationModule.nctId: "NCT05494866"
protocolSection.identificationModule.officialTitle: "IntenSify: an Open-label Phase I Trial of the CYP3A Inhibitor Cobicistat and the Cytostatics Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma to Evaluate the Combination\u0027s Pharmacokinetics, Safety and Efficacy"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.